| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |